Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis

Hubbard R, Venn A, Lewis S et al (2000) Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 161:5–8PubMedCrossRefGoogle Scholar

Harris JM, Johnston ID, Rudd R et al (2010) Cryptogenic fibrosing alveolitis and lung cancer: the BTS study. Thorax 65:70–76PubMedCrossRefGoogle Scholar

Le Jeune I, Gribbin J, West J et al (2007) The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 101:2534–2540PubMedCrossRefGoogle Scholar

Turner-Warwick M, Lebowitz M, Burrows B et al (1980) Cryptogenic fibrosing alveolitis and lung cancer. Thorax 35:496–499PubMedCentralPubMedCrossRefGoogle Scholar

Park J, Kim DS, Shim TS et al (2001) Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 17:1216–1219PubMedCrossRefGoogle Scholar

Raghu G, Collard HR, Egan JJ et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824PubMedCrossRefGoogle Scholar

Vancheri C, Failla M, Crimi N et al (2010) Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J 35:496–504PubMedCrossRefGoogle Scholar

Königshoff M (2011) Lung cancer in pulmonary fibrosis: tales of epithelial cell plasticity. Respiration 81:353–358PubMedCrossRefGoogle Scholar

Minegishi Y, Kuribayashi H, Kitamura K et al (2011) The feasibility study of carboplatin plus etoposide for advanced small cell lung cancer with idiopathic interstitial pneumonias. J Thorac Oncol 6:801–807PubMedCrossRefGoogle Scholar

Kenmotsu H, Naito T, Kimura M et al (2011) The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer. J Thorac Oncol 6:1242–1246PubMedCrossRefGoogle Scholar

Togashi Y, Masago K, Handa T et al (2012) Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer. Clin Lung Cancer 13:304–311PubMedCrossRefGoogle Scholar

Watanabe N, Taniguchi H, Kondoh Y et al (2012) Efficacy of chemotherapy for advanced non-small cell lung cancer with idiopathic pulmonary fibrosis. Respiration. doi: 10.1159/000342046 PubMedGoogle Scholar

Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319–338PubMedCrossRefGoogle Scholar

Macintyre N, Crapo RO, Viegi G et al (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26:720–735PubMedCrossRefGoogle Scholar

Johkoh T, Müller NL, Cartier Y et al (1999) Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 211:555–560PubMedCrossRefGoogle Scholar

Nishimura K, Kitaichi M, Izumi T et al (1992) Usual interstitial pneumonia: histologic correlation with high-resolution CT. Radiology 182:337–342PubMedGoogle Scholar

Song JW, Hong SB, Lim CM et al (2011) Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 37:356–363PubMedCrossRefGoogle Scholar

American Thoracic Society; European Respiratory Society (2002) American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277–304CrossRefGoogle Scholar

Schmittel A, Sebastian M, Fischer von Weikersthal L et al (2011) A German multicenter, randomized phase III trial comparing irinotecan–carboplatin with etoposide–carboplatin as first-line therapy for extensive-disease small-cell lung cancer. Ann Oncol 22:1798–1804PubMedCrossRefGoogle Scholar

Socinski MA, Smit EF, Lorigan P et al (2009) Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer. J Clin Oncol 27:4787–4792PubMedCrossRefGoogle Scholar

Okamoto H, Watanabe K, Kunikane H et al (2007) Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702. Br J Cancer 97:162–169PubMedCentralPubMedCrossRefGoogle Scholar

Kokron O, Micksche M, Titscher R et al (1982) Ifosfamide versus ifosfamide + CCNU in the treatment of inoperable small cell carcinoma of the lung. A clinical study. Onkologie 5:56–59PubMedCrossRefGoogle Scholar

Kudoh S, Kato H, Nishiwaki Y et al (2008) Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case–control study. Am J Respir Crit Care Med 177:1348–1357PubMedCrossRefGoogle Scholar

Kondoh Y, Taniguchi H, Katsuta T et al (2010) Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 27:103–110PubMedGoogle Scholar

Suda T, Kaida Y, Nakamura Y et al (2009) Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 103:846–853PubMedCrossRefGoogle Scholar

Park IN, Kim DS, Shim TS et al (2007) Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 132:214–220PubMedCrossRefGoogle Scholar

Azuma A, Hagiwara A, Kudoh S (2008) Basis of acute exacerbation of idiopathic pulmonary fibrosis in Japanese patients. Am J Respir Crit Care Med 177:1397–1398PubMedCrossRefGoogle Scholar